Technology

AddToAny

Google+ Facebook Twitter Twitter

Tech news: June 2022

This month's top tech news stories

CytoSMART

Live Cell Imaging

CytoSMART Technologies, an Axion Bio company, has announced the launch of the CytoSMART Omni FL.

It is a next-generation live-cell imaging analysis system incorporating red and green fluorescence channels into its signature CytoSMART Omni product line for the first time.

The advance reflects the company’s ongoing commitment to provide high-quality, accessible live-cell imaging to every cell biology lab and offers an innovative platform for researchers in stem cell biology, immuno-oncology, virology, toxicology, neurology, and other fields.

cytosmart.com


QIAGEN

Electrophoresis

QIAGEN has launched QIAxcel Connect – a high-speed, high-resolution and high-sensitivity nucleic acid analysis capillary electrophoresis (CE) instrument.

Compared to other CE products on the market, QIAxcel Connect offers greater convenience due to its simple set-up, greater flexibility and low running costs. It provides high analytical power, with many applications addressed. It provides a powerful new all-in-one solution that combines ease of use, high capability and economy.

qiagen.com


CN Bio

Reagent Kit

CN Bio, a leading organ-on-a-chip company that designs and manufactures single- and multi-organ microphysiological systems, has launched PhysioMimix.

It is an “in-a-box” reagent kit for non-alcoholic steatohepatitis (NASH) – the most severe form of non-alcoholic fatty liver disease.

Previously only accessible via its contract research services, CN Bio’s best-in-class NASH in vitro model has been created to support the urgent development of therapeutics.

cn-bio.com


 

Related Articles

DNA biosensor for low-cost diagnostics

A new biosensor chip that boasts an accurate and inexpensive design may increase accessibility to high-quality diagnostics, it is claimed. 

Diagnostic potential of amniotic fluid cells

A clinical research team from the University of Hong Kong is behind the discovery of applying amniotic fluid cells obtained during 16-24 weeks of pregnancy as a novel sample type for RNA sequencing in prenatal diagnosis.

CRISPR and developing diagnostics

In a first for the genetic toolset CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA and single- and double-stranded DNA.

Top